BREAKOUT STOCK ALERT
ECOR - electroCore, Inc. - Common Stock
Initial Alert Price: $2.26
Potential Price: $3.3
Potential Gains: 46.02
Stop Loss Limit: $
Re-Entry Trade Alert:
ECOR is currently trading at the bottom of it's long-term trend line providing the opportunity to re-enter into the trade and retest the $3.30 Levels for a potential 40-45% Swing Trade over the next few weeks.
The company announced on Feb. 24th that the completion of patient enrollment in SAVIOR-1, or "Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19."
The company also announced the Australian Government Department of Health approved the company's GammaCore Migraine Therapy Vagus Nerve Electrical Simulator.
From a fundamental long-term outlook, the company is showing 24% EPS YoY and +197% Growth in Net Profit Margin YoY. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
ECOR - electroCore, Inc. - Common StockInitial Alert Price: $2.26
Potential Price: $3.3
Potential Gains: 46.02
Stop Loss Limit: $
Re-Entry Trade Alert:
ECOR is currently trading at the bottom of it's long-term trend line providing the opportunity to re-enter into the trade and retest the $3.30 Levels for a potential 40-45% Swing Trade over the next few weeks.
The company announced on Feb. 24th that the completion of patient enrollment in SAVIOR-1, or "Prospective, Randomized, Controlled Study to Evaluate the Effect of Non-Invasive Electrical Vagus Nerve Stimulation on Respiratory Symptoms due to COVID-19."
The company also announced the Australian Government Department of Health approved the company's GammaCore Migraine Therapy Vagus Nerve Electrical Simulator.
From a fundamental long-term outlook, the company is showing 24% EPS YoY and +197% Growth in Net Profit Margin YoY. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
관련 발행물
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.